Integral Diagnostics Ltd
ASX:IDX
Intrinsic Value
Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. [ Read More ]
The intrinsic value of one IDX stock under the Base Case scenario is 4.49 AUD. Compared to the current market price of 2.25 AUD, Integral Diagnostics Ltd is Undervalued by 50%.
Valuation Backtest
Integral Diagnostics Ltd
Run backtest to discover the historical profit from buying and selling IDX stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Integral Diagnostics Ltd's business.
What risks and challenges
does Integral Diagnostics Ltd face in the near future?
Summarize the latest earnings report
of Integral Diagnostics Ltd.
Provide P/E
for Integral Diagnostics Ltd and its competitors.
Balance Sheet Decomposition
Integral Diagnostics Ltd
Current Assets | 65.7m |
Cash & Short-Term Investments | 18m |
Receivables | 35.6m |
Other Current Assets | 12.1m |
Non-Current Assets | 680.1m |
Long-Term Investments | 5k |
PP&E | 276m |
Intangibles | 404.1m |
Current Liabilities | 86.1m |
Accounts Payable | 28.3m |
Other Current Liabilities | 57.8m |
Non-Current Liabilities | 359.4m |
Long-Term Debt | 343.6m |
Other Non-Current Liabilities | 15.7m |
Earnings Waterfall
Integral Diagnostics Ltd
Revenue
|
456.3m
AUD
|
Cost of Revenue
|
-21.8m
AUD
|
Gross Profit
|
434.6m
AUD
|
Operating Expenses
|
-392.2m
AUD
|
Operating Income
|
42.4m
AUD
|
Other Expenses
|
-100.2m
AUD
|
Net Income
|
-57.9m
AUD
|
Free Cash Flow Analysis
Integral Diagnostics Ltd
What is Free Cash Flow?
IDX Profitability Score
Profitability Due Diligence
Integral Diagnostics Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Integral Diagnostics Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
IDX Solvency Score
Solvency Due Diligence
Integral Diagnostics Ltd's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Score
Integral Diagnostics Ltd's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IDX Price Targets Summary
Integral Diagnostics Ltd
According to Wall Street analysts, the average 1-year price target for IDX is 2.46 AUD with a low forecast of 1.87 AUD and a high forecast of 3.24 AUD.
Shareholder Return
IDX Price
Integral Diagnostics Ltd
Average Annual Return | 13.16% |
Standard Deviation of Annual Returns | 39.22% |
Max Drawdown | -68% |
Market Capitalization | 525.2m AUD |
Shares Outstanding | 233 249 475 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-10-21. The firm is principally engaged in providing medical imaging services to patients and their referrers across Australia and New Zealand. The firm offers its services through its three brands in Australian states, which include Lake Imaging in Victoria, South Coast Radiology and Imaging Queensland in Queensland and Apex Radiology in Western Australia. IDX also operates in New Zealand through the Ascot Radiology, SRG Radiology and Trinity MRI brands. The firm has approximately 72 radiology clinics, including 26 comprehensive sites. IDX offers its services through its subsidiaries.
Contact
IPO
Employees
Officers
The intrinsic value of one IDX stock under the Base Case scenario is 4.49 AUD.
Compared to the current market price of 2.25 AUD, Integral Diagnostics Ltd is Undervalued by 50%.